norlorcainide

structure given in first source

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Cardiac Arrhythmias (Arrythmia) 01/01/1985 - "This study evaluated the long-term efficacy of lorcainide in suppressing chronic symptomatic PVCs, and examined the relation of arrhythmia suppression to plasma concentrations of lorcainide and norlorcainide. "
2.	Ventricular Premature Complexes (Premature Ventricular Contraction) 02/01/1984 - "In order to characterize the accumulation of lorcainide and norlorcainide and to define the onset of antiarrhythmic action during lorcainide loading, 9 patients with frequent ventricular ectopic beats were studied. "
3.	Headache (Headaches) 03/01/1986 - "Mean lorcainide levels were 0.287 micrograms/ml and mean norlorcainide levels were 0.377 micrograms/ml. Only 2 of 12 subjects in group I experienced headache, dizziness, or sleep disturbance, compared to 12 of 14 subjects in group II (p less than 0.01). "
4.	Dizziness (Lightheadedness) 03/01/1986 - "Mean lorcainide levels were 0.287 micrograms/ml and mean norlorcainide levels were 0.377 micrograms/ml. Only 2 of 12 subjects in group I experienced headache, dizziness, or sleep disturbance, compared to 12 of 14 subjects in group II (p less than 0.01). "

1.	lorcainide